Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -36.23% is 99% above its 1-year average of -2729.83%, near the high end of its 1-year range (-2984.70%–-36.23%).
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
-36.23%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$52.95M
EBITDA Margin
-36.23%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.01M
EBITDA Margin
-5927.25%
TTM Avg
-3470.39%
3Y Avg
-2050.54%
5Y Avg
-1465.25%
Market Cap
$51.58M
EBITDA Margin
-61570.00%
TTM Avg
-181077.86%
3Y Avg
-90538.93%
5Y Avg
-60359.29%
Market Cap
$50.51M
EBITDA Margin
-108.45%
TTM Avg
-10676.44%
3Y Avg
-10454.97%
5Y Avg
-429870.64%
Market Cap
$50.25M
EBITDA Margin
-9115.35%
TTM Avg
-8798.34%
3Y Avg
-6751.54%
5Y Avg
-5839.94%
Market Cap
$49.96M
EBITDA Margin
-10794.00%
TTM Avg
-9994.66%
3Y Avg
-8986.60%
5Y Avg
-8678.68%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $52.95M | -36.23% | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | -5927.25% | -3470.39% | -2050.54% | -1465.25% |
| INmune Bio, Inc. (INMB)vs › | $51.58M | -61570.00% | -181077.86% | -90538.93% | -60359.29% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $50.51M | -108.45% | -10676.44% | -10454.97% | -429870.64% |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -9115.35% | -8798.34% | -6751.54% | -5839.94% |
| Aldeyra The (ALDX)vs › | $55.72M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.96M | -10794.00% | -9994.66% | -8986.60% | -8678.68% |
| Celularity Inc. (CELU)vs › | $49.50M | -203.44% | -129.78% | -288.25% | -438.27% |
Gross Margin
N/A
EBITDA Margin
-36.2%
Operating Margin
N/A
Net Margin
N/A
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2015-12-31 | -2474.95% |
| 2015-09-30 | -2984.70% |
